Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Rituximab

Brand: 
NICE TA: 
Indication: Autoimmune haemolytic anaemia
Disease category: Immune system and Malignant Disease
Commissioning responsibility: CCG
PbR excluded: Yes

Background

Rituximab is recommended as an alternative treatment for adults with AIHA where patients are contraindicated to or fail to respond to standard active treatments (e.g. corticosteroids).
Treatment requires initiation and continuation by specialist haematology services.

Recommendation

LMMG recommendation: Red
Click here to find the definitions for the colour classifications

Reason for decision:  Specialist medicine

Supporting documents:

New Medicines Recommendation - Rituximab In AIHA (699.2 KiB)

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red

Red

Red

Red

Red